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Abstract
Background: Identification of famous landmarks (FLI), famous faces (FFI) and recognition of facial emotions (FER) is affected
early in the course of Alzheimer’s disease (AD). FFI, FER and FLI may represent domain specific tasks relying on activation of
distinct regions of the medial temporal lobe, which are affected successively during the course of AD. However, the data on
FFI and FER in MCI are controversial and FLI domain remains almost unexplored.
Objectives: To determine whether and how are these three specific domains impaired in head to head comparison of
patients with amnestic MCI (aMCI) single domain (SD-aMCI) and multiple domain (MD-aMCI). We propose that FLI might be
most reliable in differentiating SD-aMCI, which is considered to be an earlier stage of AD pathology spread out, from the
controls.
Patients and Methods: A total of 114 patients, 13 with single domain (SD–aMCI) and 30 with multiple domains (MD–aMCI),
29 with mild AD and 42 controls underwent standard neurological and neuropsychological evaluations as well as tests of
FLI, FER and FFI.
Results: Compared to the control group, AD subjects performed worse on FFI (p = 0.020), FER (p,0.001) and FLI (p,0.001),
MD-aMCI group had significantly worse scores only on FLI (p = 0.002) and approached statistical significance on FER (0.053).
SD-aMCI group performed significantly worse only on FLI (p = 0.028) compared to controls.
Conclusions: Patients with SD-aMCI had an isolated impairment restricted to FLI, while patients with MD–aMCI showed
impairment in FLI as well as in FER. Patients with mild dementia due to AD have more extensive impairment of higher visual
perception. The results suggest that FLI testing may contribute to identification of patients at risk of AD. We hypothesize
that clinical examination of all three domains might reflect the spread of the disease from transentorhinal cortex, over
amygdala to fusiform gyrus.
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Introduction
Alzheimer disease (AD) is considered to be a continuum from
preclinical stage through the prodromal stage represented by mild
cognitive impairment (MCI) syndrome to the dementia syndrome
[1,2,3]. The difference between MCI and dementia is in preserved
functional capacity of MCI individuals whereas cognitive impair-
ment is present in both stages. It is well accepted that beside the
impairment of episodic memory, there are also other cognitive
domains affected in early stages of AD, such as semantic memory,
executive functions, attention, language, visuo-constructive skills
and spatial navigation [4,5,6,7].
The individuals with MCI form a heterogeneous group, where
those with memory impairment – amnestic MCI (aMCI), seem to
be more vulnerable to convert to AD with estimated average rate
of conversion 12% per year [8]. Some of aMCI subjects present
with isolated memory impairment – aMCI single domain (SD-
aMCI), while others present with impairment in additional
domains to memory – aMCI multiple domain (MD-aMCI) [9].
Individuals with MD-aMCI are more likely to convert to dementia
than SD-aMCI subjects [10] and might thus represent a more
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advanced stage of AD pathology than SD-aMCI subjects.
However, not all of the individuals with aMCI syndrome convert
to dementia; some may remain stable or even reverse back to
normal cognition. Therefore much effort is spent to identify
subjects at higher risk with putative underlying AD pathology who
are considered to be at prodromal stages of AD.
Besides the structural and functional neuroimaging, focused on
the hippocampus and related structures, and the cerebrospinal
fluid assessment of amyloid-b peptide, tau, and phosphorylated tau
proteins, specific memory tests play an important role in
identification of the high risk MCI subjects. Specifically, ‘‘amnestic
syndrome of the hippocampal type’’ [11] seems to be characteristic
for prodromal stages of AD [12,13]. Besides clinically well-
established episodic memory tests [14], there has been ongoing
search for novel instruments aiming even for earlier AD related
changes with highest possible sensitivity and specificity.
Higher visual perception, which includes identification and
recognition of faces and landmarks as well as recognition of facial
emotions, is dependent on the medial temporal lobe structures that
are affected early in the course of AD. There is some empirical
evidence that these domains might be affected already in the MCI
subjects [15,16,17].
Studies on famous faces identification (FFI) report consistently
impairment of this domain in subjects with dementia due to AD
[18,19,20] while studies with MCI subjects report rather
inhomogeneous results [15,16,21,22].
Another domain affected early in patients with AD is
recognition of facial emotions (FER) [17,23]. Reports on FER
impairment in MCI are controversial [24,25,26,27]. However,
evidence favors the hypothesis that worse FER is associated with
MCI compared to normal aging [28].
Only very sporadic data exists on famous landmark identifica-
tion (FLI) in AD – casuistic report is available of an AD patient
with impaired discrimination between famous and unknown
buildings despite of preserved identification of faces [29]. The
single study with FLI in MCI [16] found that MCI subjects were
impaired in naming of famous buildings, famous faces, and of well-
known objects compared to controls.
The inconsistent results of FLI, FFI and FER impairment in
MCI might be the result of different study populations: Some
studies compared subgroups of patients with amnestic MCI while
the others also included those with non-amnestic MCI. In
addition, these studies use different paradigms exploring each
specific domain. Some studies rely on testing the naming of famous
faces/objects which also involves some semantic processing
[15,16] while others use face matching tasks, comparing similar-
ities or differences in facial features or emotions [17,21,22].
Recognizing famous faces, famous landmarks and emotions is
probably domain specific task. Imaging studies in cognitively
healthy subjects have shown category specific activation in medial
temporal structures during tasks with buildings, emotion and
famous faces recognition. Parahippocampal/lingual gyri are more
responsive to buildings [30]; amygdala and adjacent cortex are
activated during emotion recognition [31,32], while the fusiform
gyri are preferentially responsive to famous faces [22,33].
Clinical staging of AD corresponds with spread of tau pathology
(formation of typical argyrophilic neurofibrillary tangles and
neuropil threads within the neurons) characterized in Braak
staging [34], where stage I-IV corresponds with the spread of
pathology in the direction from transentorhinal and parahippo-
campal cortices, to hippocampus, fusiform gyrus and beyond [35].
We suggest that the impairment in identification of these domain
specific categories (FER, FFI and FLI) could appear based on their
structural correlates in a timely manner during the course of AD
following the Braak stages. We have used well defined groups of
patients (SD-aMCI, MD-aMCI and mild AD).
The aim of our study was to perform head to head comparison
of these three domain specific paradigms relying on various medial
temporal lobe structures in well-defined subgroups of aMCI and
mild AD and to assess whether these tests can reliably distinguish
SD-aMCI and MD-aMCI from controls. Based on the domain
specific structural correlates, we expected that all 3 tasks will be
affected in mild AD, while only FER and FLI would be impaired
in aMCI compared to controls. Assuming that SD-aMCI might be
an earlier stage of AD pathology then MD-aMCI, we hypothesize
that FLI, which is relying on the parahippocampal gyrus, a brain
region affected very early in the course of AD, might be more
reliable in distinguishing SD-aMCI from controls.
Materials and Methods
1. Participants
The study was approved by the institutional ethics committee of
University Hospital Motol and all participants provided a written
informed consent. In demented people a research consent form
was approved and signed on the patient’s behalf by the caregiver.
A total of 114 subjects were recruited at the Memory Clinic of the
University Hospital Motol, 29 patients with mild AD, 43 patients
with aMCI (13 SD–aMCI and 30 MD–aMCI), and 42 cognitively
healthy controls. Cognitively healthy participants were recruited
from the older adults attending University of the Third Age at
Charles University in Prague or from relatives of patients of the
Memory Clinic, Motol University Hospital in Prague. Subjects
with memory complaints, history of neurological or psychiatric
disease, psychiatric medication usage, or abnormal neurological
examination including gait or movement difficulties were not
included. Participants meeting DSM IV-TR criteria for dementia,
Petersen’s criteria for MCI [36] or scoring more than 1.5 SD
below the age- and education-adjusted norms on neuropsycho-
logical examination were not included into the control group.
MCI and AD subjects were referred to the clinic by general
practitioners, neurologists, psychiatrists, and geriatricians. AD
patients met the NINDS ADRDA diagnostic criteria and all
participants with aMCI met published revised clinical criteria for
MCI [36] including memory problem reported by patient or
caregiver, generally intact activities of daily living, evidence of
cognitive dysfunction with predominant memory involvement on
neuropsychological testing, and absence of dementia. The aMCI
patients scored in memory tests 1.5 standard deviation points
below the mean of age- and education-adjusted norms. The aMCI
subjects were further classified into SD-aMCI and MD-aMCI.
SD-aMCI patients had an isolated memory deficit. Cognitive
impairment in attention and executive function, language skills, or
visuospatial skills in addition to memory impairment was used to
classify subjects as having MD-aMCI. Patients with a Hachinski
Ischemic Scale score .4 [37] or with a history of other
neurological or psychiatric disorders including depression –
scoring .5 in the short 15 items Geriatric depression scale [38]
were not included in the study. All participants underwent
standard neurological and laboratory evaluations, 1.5T magnetic
resonance brain imaging, clinical scaling Mini Mental State
Examination (MMSE) [39] and complex neuropsychological
testing. Patients with extensive vascular changes – Fazekas score
3 [40], lacunar stroke, meningioma or other severe structural
pathology on brain MRI were excluded from the study.
FLI in MCI
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2. Neuropsychological evaluation
The neuropsychological battery was covering 1) memory,
measured by Auditory Verbal Learning Test trials 1–6 and the
Auditory Verbal Learning Test Delayed Recall [41,42], Rey-
Osterrieth Complex Figure Recall condition [43] and modified
version of FCSRT called Enhanced Cued Recall (ECR test in
Czech validated version) [13,44]; 2) attention/processing speed,
measured with the Digit Span Backwards [45] and Trail Making
Test A [46]; 3) executive functions, measured with the Trail
Making Test B [46] and Controlled Oral Word Association
(COWAT) test [47]; 4) language, measured with the Boston
Naming Test [48]; and 5) visuospatial functions measured with the
Rey-Osterrieth Complex Figure Copy condition [43]. The score
for each domain was expressed as a unit weighted composite score
from the relevant tests. The Trail Making Test subtasks, which are
expressed in seconds to completion, were reverse scored before the
means were generated. Boston Naming Test scores were used only
for MCI patient classification. The MMSE was administered to
measure global cognitive functions.
3. Test of famous faces identification
This test was adapted from Keane’s study [49] and adjusted for
a Czech population [50]. Faces of 10 highly famous persons
(politicians, actors, musicians, etc.) and 10 unfamiliar faces were
presented to the subjects in a fixed pseudo-random order. We used
pictures of famous people from visual media. For each face, the
participant decided whether the person was familiar or not. The
performance was measured by the number of faces correctly
recognized as familiar or unfamiliar (correct rejections) with
possible scores ranging from 0–20. The battery of famous faces
was composed only from Czech personalities. The test was
administered by a single qualified test administrator to avoid
interrater variability.
4. Test of famous landmarks identification (Fig.1)
The famous objects were depicted considering Czech generally
well known buildings and international buildings well-known
within the Czech population. Identification of these objects was
previously tested on a set of elderly cognitively healthy volunteers.
Items which were not recognized by 20% or more of the
volunteers were not included in the test. The administration of the
test was fully computer based to avoid interrater variability.
Pictures of 25 highly famous places worldwide (buildings,
bridges, statues etc.) and 25 matched pictures of unfamiliar places
were presented in a fixed pseudo-random order. For each place,
the participant decided whether the place was generally familiar or
not. Each correctly recognized place as familiar or unfamiliar
(correct rejections) was scored with one point – score range 0-50.
5. Test of facial emotions recognition
Pictures from the Ekman and Friesen series [51] representing
five basic emotions, i.e., happiness, anger, sadness, fear and disgust
were used to measure recognition of facial emotions. Each
category of the five emotions was presented by using five pictures
of different faces. The description of each emotion was printed
under each picture in a random order in multiple choices. The
participants were asked to point to the emotion which correlated
best with the facial expression shown above. There were 25 trials
(five for each emotion) with possible scores ranging from 0–25.
The emotions were randomly presented and no target picture was
used more than once.
6. Statistical evaluation
Inferential statistics involved a one-way analysis of variance
(ANOVA) to evaluate between-group differences in age, MMSE,
and neuropsychological tests. The x2 test was used to evaluate
differences in proportions (gender). The between-group differences
in the main analyses with FFI, FER and FLI were evaluated using
a general linear model (GLM). As the groups differed in the level
of education, education was used as a covariate in these models. In
the second GLM model we controlled for global cognitive
functioning by adding a MMSE score to the previous model. All
post hoc analyses were carried out with the Sidak test.
In the correlation analyses, first, zero-order Pearson correlation
with Holm-Bonferroni correction for multiple comparisons was
used to assess the relationship between the FFI, FER and FLI and
neuropsychological tests. Subsequently, partial Pearson correlation
with Holm-Bonferroni correction was used to control for the effect
of group membership. Due to low variability of the scores across
the groups, we used all participants within one correlation analysis.
This step did not affect the results. The significance level was set at
two-tailed 0.05. All analyses were run using SPSS 13.0 for
Windows.
Results
The groups did not differ in age (F[3,110] = 2.11; p = 0.103) and
gender (x2(3) = 3.03; p = 0.387), but in education (F[3,110] = 8.65;
p,0.001), specifically AD (p,0.001) and SD-aMCI (p = 0.023)
had less years of education than the control group. The
demographical and neuropsychological characteristics are pre-
sented in Table 1.
There was a moderate positive correlation between FER and
FLI, and a low positive correlation between FFI and FLI and
between FFI and FER. Correlations between FFI, FER, FLI,
MMSE and cognitive domains are presented in Table 2. When we
controlled for a group membership in the correlation analyses,
only a low positive correlation between FER and FFI and between
FER and FLI together with a moderate positive correlation
between FLI and MMSE remained significant; see Table 2.
In the main GLM analysis controlling for education, we found
significant main effects for group in FFI (F[3,109] = 3.54;
p = 0.017), FER (F[3,109] = 12.00; p,0.001) and FLI
(F[3,109] = 15.60; p,0.001) tests. Specifically, the SD-aMCI was
impaired only in FLI (p = 0.028) compared to the control group.
Further, the MD-aMCI had lower performance in FLI (p = 0.002)
Figure 1. Test of famous landmarks identification. Illustration of
two famous places for the Czech population and two similar but
unfamiliar places. For each place, the participant decided whether the
place was familiar or not.
doi:10.1371/journal.pone.0105623.g001
FLI in MCI
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compared to the control group. Differences between the MD-
aMCI and the control group in FER approached statistical
significance (p = 0.053). Finally, the AD group had lower
performance in all three main tests, FFI (p = 0.020), FER (p,
0.001) and FLI (p,0.001), compared to the control group. There
were no differences between the SD-aMCI and MD-aMCI
groups. For the differences in the performance among the groups
see in Figure 2, 3, 4. In the second GLM analysis controlling for
education and MMSE score, the main significant effect remained
for the FLI (F[3,108] = 5.97; p = 0.001) and FER (F[3,108] = 5.38;
p = 0.002) tests, but not for the FFI (F[3,108] = 2.21; p = 0.091).
Specifically, the differences between the SD-aMCI and the control
group approached statistical significance in FLI (p = 0.057).
Further, the differences between the MD-aMCI and the control
group remained significant for FLI (p = 0.013), but not for FER
(p = 0.083). Finally, the differences between the AD and the
control group remained significant for FER (p = 0.001) and FLI
(p = 0.001) tests. The differences between the SD-aMCI and MD-
aMCI groups remained non-significant.
Discussion
The findings indicate that SD-aMCI patients performed
significantly worse than controls on FLI but not on FER and
Table 1. Demographic characteristics of the groups.
Controls (n =42) SD-aMCI (n =13) MD-aMCI (n=30) mild AD (n=29) P value Effect size
Age 71.55 (4.95) 72.62 (7.68) 71.93 (9.18) 74.41 (8.44) 0.103a 0.054c
Sex W/M 25/17 (0.60) 9/4 (0.69) 13/17 (0.43) 17/12 (0.59) 0.387b 0.162d
Education 15.79 (2.59) 13.23 (2.89)* 14.83 (3.44) 12.59 (2.21)*** ,0.001a 0.190c
MMSE 28.54 (1.44) 27.04 (2.32) 26.02 (2.86)*** 19.79 (3.26)*** ,0.001a 0.617c
FCSRT 15.88 (0.33) 12.25 (2.71) 13.81 (3.03)* 9.00 (1.41)*** ,0.001a 0.362c
AVLT 1-6 58.41 (12.15) 30.75 (9.71)*** 29.00 (6.57)*** 30.0 (2.83) *** ,0.001a 0.701c
AVLT 30 10.18 (3.38) 1.25 (1.49)*** 2.24 (1.64)*** 0.50 (0.71) *** ,0.001a 0.752c
ROCF - R 18.38 (6.17) 6.80 (4.10)*** 8.95 (5.16)*** 1.50 (2.12)*** ,0.001a 0.501c
DSB 4.94 (0.97) 4.50 (1.41) 4.19 (1.66) 4.50 (0.71)** 0.003a 0.193c
TMT A 40.68 (8.72) 45.63 (30.66) 60.14 (23.80) 65.00 (32.53)** 0.001a 0.172c
TMT B 87.56 (19.74) 113.75 (36.51) 186.62 (119.79)** 355.00 (205.06)*** ,0.001a 0.353c
COWAT 43.24 (11.86) 37.88 (9.99) 30.76 (10.40)** 25.50 (7.78)*** ,0.001a 0.249c
ROCF - C 31.76 (1.79) 31.88 (2.03) 26.95 (5.24)* 16.75 (9.55)*** ,0.001a 0.448c
BNT err. 2.50 (1.89) 5.25 (2.44) 6.19 (3.81)* 12.40 (5.76)*** ,0.001a 0.800c
FFI 18.61 (1.48) 18.38 (1.66) 17.66 (2.72) 16.79 (2.90)* 0.017 0.098c
FER 21.93 (2.23) 20.00 (2.20) 20.03 (2.54) 17.13 (4.02)*** ,0.001 0.223c
FLI 42.27 (3.79) 37.62 (4.25)* 37.90 (4.72)** 33.17 (5.91)*** ,0.001 0.317c
Mean values (SD); Auditory Verbal Learning Test (AVLT) trials 1–6 and AVLT Delayed Recall (AVLT 30), Rey-Osterrieth Complex Figure Copy (ROCF - C) and Recall (ROCF –
R), Free and Cued Selective Reminding Test (FCSRT) total recall, Digit Span Backward (DSB), Trail Making Test (TMT) A and B, Controlled Oral Word Association (COWAT),
Boston Naming Test errors (BNT err.); one-way ANOVA - between-group differences.
aANOVA, bX2 test, cPartial eta 2, dCrame´r’s V, * p,.05, **,.01, ***,.001 (compared to the control group) Note: Partial eta2 of 0.2 corresponds to Cohen’s d of 1.0 with our
sample size, Crame´r’s V of about 0.175 corresponds to Cohen’s d of 0.356.
doi:10.1371/journal.pone.0105623.t001
Table 2. Correlations of FFI, FER and FLI with cognitive domains (EGM – correlations controlled for effect of group membership).
FFI FER FLI
MMSE EGM 0.127 0.114 0.407**
0.313* 0.411** 0.681***
memory EGM 0.220 0.171 0.139
0.370** 0.438** 0.531***
attention EGM 0.248 0.248 0.177
0.309* 0.333* 0.299*
executive EGM 0.092 0.228 0.245
0.247 0.425** 0.511***
visuospatial EGM 20.094 20.110 0.228
0.104 0.181 0.504***
* p,0.05, **,0.01, ***,0.001 values in bold indicate significant correlations after Holm-Bonferroni correction for multiple comparisons. The tests used for testing each
cognitive domain are closely described in the methods.
doi:10.1371/journal.pone.0105623.t002
FLI in MCI
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FFI, MD-aMCI scored worse on FLI and approached statistical
significance in FER performance. Further, AD patients exhibited
impairment in all 3 visual domains. The findings could not be
explained by differences in education but were partially modified
by MMSE.
In our previous work we have shown that FER but not FFI may
be impaired in MD-aMCI and that neither FER nor FFI is
impaired in SD–aMCI [27] which is consistent with the results of
this study using different patients’ cohort. Similar finding was
reported from the study of University of California Los Angeles,
which also compared two groups of aMCI subtypes [26].
However, FLI seems to be impaired in both SD-aMCI as well
as MD-aMCI group of patients compared to controls and no
differences in FLI performance seem to be present between SD-
aMCI and MD-aMCI patients. This suggests that FLI could be
helpful in combination with other scales in cognitive screening for
aMCI in geriatric population.
On the contrary, impairment of FFI does not seem to be very
sensitive for MCI. Studies with face matching tasks in MCI
subjects suggested no differences in the number of correct answers,
but only longer completion time when compared to normal
controls [21,22]. This is consistent with our results where no
impairment of FFI compared to controls was found in any of the
aMCI subtype and both, SD-aMCI as well as MD-aMCI group,
performed similarly when compared with each other.
On the other hand, the Barcelona group [15] reported that
slight FFI impairment may be predictive of dementia due to AD
developed 2 years later and the Cambridge group did report
impairment of FFI in MCI [16]. The different results can be
explained by using of different paradigm. Both studies relay the
testing of these categories on naming faces and/or buildings,
which involves a complex processing network including involve-
ment of stored semantic knowledge about the people or buildings.
Psychological studies have suggested that the task of fully
identifying and naming a famous person is achieved by a cascade
of sequential processing stages [52]: the pre-semantic stage, when
recognition of famous faces is impaired only in the visual domain,
the semantic stage, when loss of biographical information about
known people (person-specific semantics) occurs regardless of the
stimulus modality; and the post-semantic lexical retrieval stage,
when name retrieval is impaired but semantic information is
retrieved correctly. In our study however, subjects did not name
the faces/buildings, they were just deciding whether the presented
item was famous or not. This is similar to paradigm used in a
different Cambridge study [19], which indicated that pure
recognition and sense of familiarity can occur independently of
accessing semantic information.
Results of our present study show that impairment of FLI is
present in aMCI subjects and it can discriminate both aMCI
subtypes from controls. There are very few studies on recognizing
famous or familiar buildings or landmarks in AD and MCI
[16,29]; the results of these studies correspond with our findings of
Figure 2. Differences across groups in the FFI test. The total
number of faces correctly recognized as familiar or unfamiliar (correct
rejections) in each group is depicted. * p,0.05. Note: mean, median
and interquartile ranges characterise performance of each group. FFI =
Test of famous faces identification, SD-aMCI = single domain amnestic
mild cognitive impairment, MD-aMCI = multiple domain amnestic mild
cognitive impairment, AD = Alzheimer’s disease dementia.
doi:10.1371/journal.pone.0105623.g002
Figure 3. Differences across groups in the FER test. The total
number of correctly recognized emotions in each group is depicted.
* p,0.05, *** p,0.001. Note: mean, median and interquartile ranges
characterise performance of each group. FER = Test of facial emotions
recognition, SD-aMCI = single domain amnestic mild cognitive
impairment, MD-aMCI = multiple domain amnestic mild cognitive
impairment, AD = Alzheimer’s disease dementia.
doi:10.1371/journal.pone.0105623.g003
Figure 4. Differences across groups in the FLI test. The total
number of correctly recognized places as familiar or unfamiliar (correct
rejections) in each group is depicted. * p,0.05, ** p,0.01, *** p,0.001.
Note: mean, median and interquartile ranges characterise performance
of each group. FLI = Test of famous landmarks identification, SD-aMCI
= single domain amnestic mild cognitive impairment, MD-aMCI =
multiple domain amnestic mild cognitive impairment, AD = Alzhei-
mer’s disease dementia.
doi:10.1371/journal.pone.0105623.g004
FLI in MCI
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FLI impairment in AD as well as in MCI and to a more
pronounced FLI than FFI impairment in these subjects [53].
According to the literature the FLI, FER and FFI depends on
various anatomical structures [17,21,30,31,32,54] therefore the
differences in the impairment of specific domains among the
groups of patients with different severity of cognitive impairment
might be caused by distinct neuropathological correlates involved
in each paradigm. According to Braak and Braak [35], underlying
AD pathology spreads gradually; affecting medio-temporal struc-
tures in the typical order and clinical staging corresponds with tau
pathology and Braak staging [34]. Our results could be interpreted
in this context. FLI refers to parahippocampal/lingual gyri [30].
Lesion of the parahippocampal gyrus may lead to inability to
recognize salient environmental landmarks during spatial naviga-
tion and may thus cause significant spatial navigation deficits [54].
Transentorhinal cortex, a part of parahippocampal gyrus is the
first affected by the AD pathology. This corresponds with a view
that SD-aMCI is an earlier stage than MD-aMCI, where besides
FLI also FER is impaired. FER depends on the function of the
amygdala [31,32] which is affected later in the course of AD [35].
Spreading of the pathology beyond the mesiotemporal struc-
tures in subjects with dementia would correspond to our
observation that FFI impairment relying on more lateral regions
within temporal neocortex [17,21] was present together with FLI
and FER impairment only in demented subjects.
Our study shares limitation with similar studies in the field
which is the absence of neuroimaging correlates. Further, we used
a relatively small sample size, which could also influence the
results. Especially, due to the small sample size we failed to find
differences between SD-aMCI and MD-aMCI groups in FER,
although MD-aMCI patients seem to be impaired unlike SD-
aMCI patients when compared to the control group. We could not
exclude problems with familiarity assessment as an influencing
factor, similarly like the other studies on familiarity cited in this
article. We acknowledge that some studies in aMCI reported
difficulties with assessing familiarity in these subjects [55] and
over-reliance on familiarity as well [56]. However other studies did
not find impaired familiarity-based recognition in contrary to
impaired recognition based on recollection in MCI subjects,
suggesting that recollection and familiarity might be independent
processes associated with distinct anatomical substrates [57,58].
PET studies also show that the distinction of famous and non–
famous stimuli independently of its category [30,59,60,61] relies
on anterior temporal pole, which as a part of associative neocortex
is affected later in the course of AD pathology spread out (Braak
IV). This might suggest that the statistical differences observed in
aMCI subjects reflect the domain specific differences in the task
rather than difficulties in familiarity assessment. We cannot also
exclude a ceiling effect in the FFI task, which could cover up some
of the group differences in performance within this task. The
selection of participants is limited because the diagnosis of aMCI
was based only on a complex neuropsychological examination and
no imaging or biochemical biomarkers were used. Therefore we
could not exclude subjects which would not convert to AD in a
short time.
However, this study has potential implications for future
research. We have introduced a new paradigm on famous
landmark identification which allows direct comparison with
analogical paradigm described in Keane’s study [49] on identifi-
cation of famous faces. This is to our knowledge the first head to
head comparison of these 3 paradigms, which allows interpreta-
tion of the usefulness of each paradigm for distinguishing aMCI
patients from the controls. The tasks of FLI, FER and FFI
probably involve segregated neurocognitive networks part of
which are affected in prodromal stages of AD and future research
is needed to test this hypothesis. Especially studies with the
employment of functional neuroimaging would be of a great
advantage. The early spread-out of pathology through the visual
ventral stream is a specific feature for AD therefore assessment of
these domains could also help in early differential diagnosis of AD
versus other forms of dementia such as frontotemporal lobar
degeneration where ventral visual stream is spared and diffuse
Lewy body disease where dorsal visual stream is early involved.
Another important future implication for research would be to
assess how FLI impairment correlates with real spatial navigation
difficulties. Spatial orientation difficulties is a well-known and
stressful feature reported by caregivers of individuals with
dementia due to AD and impairment in spatial navigation is one
of the early markers of MCI due to AD pathology while it
correlates with hippocampal type of memory impairment [62] and
with right hippocampal volume [63]. FLI is related to the ability of
recognizing landmarks important for navigation. Recent findings
indicated that learning and subsequent recalling or recognition of
landmarks or famous places may not be dependent on the way
how and in which environment they were perceived. In the study
addressing this issue [64] similar results were found when
landmarks or places visited by subjects were learned in the real-
world and virtual environment, respectively, and also when they
were subsequently recalled or recognized from photographs and
video clips. The more unique an object is within an environment
and the more it is perceived as having a stable spatial position, the
more likely it is that it will be used as a landmark. Objects rated as
more stable (larger and less ‘‘portable’’) automatically evoked
landmark-based neural processes in the study subjects [65]. In line
with this, it has also been shown that making spatial judgments
with reference to stable environmental objects (e.g., a large
buildings) compared with unstable objects (e.g., a ball) elicit
greater activity in navigationally relevant medial parietal and
temporal brain regions, including the hippocampus (for review see
[66,67]). Objects included in our FLI test fulfil both of these
criteria (shape uniqueness and stability) hence could be relevant for
testing one part of complex spatial navigation behaviour used in.
Objects used for navigation in the neighbourhood and town are
usually landmarks learned long time ago. Therefore difficulties in
recognizing them as familiar could be part of the problem
everyday navigation scenario of AD subjects. Establishing the
relationship between FLI and spatial navigation impairment might
confirm the usefulness of FLI in assessment in MCI at high risk for
conversion to AD dementia. The practical implication may be that
being impaired in the FLI can reflect the difficulties with
orientation in the real environment, which may contribute to
driving impairments and getting lost.
Conclusions
Our results suggest that the tasks with recognizing famous
landmarks, facial emotions and familiar faces involve segregated
neurocognitive networks and might be impaired in a time order in
relation to the course of AD. Since these tests refer to different
brain structures which are considered to be related to various
stages of the disease, assessment of FLI, FER and FFI may provide
valuable clinical information indirectly reflecting underlying
pathology. Future research is needed to match pathological
changes, test performance and longitudinal data.
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